Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android

The purpose of this chapter is to define and describe the factors that an investigator needs to consider in conducting a multicenter, randomized clinical trial evaluating various treatments in breast surgical oncology. Many examples and experiences will be drawn from the National Surgical Adjuvant Breast and Bowel Project (NSABP), which has had a 50-year history of conducting such evaluations.

The goals of this chapter are to make the reader aware of the principles that lead to a verifiable scientific discovery via the conduct of a clinical trial and to direct the reader to other resources that further elucidate and educate. Additional goals are to increase the reader's awareness of the potential obstacles and pitfalls that can be associated with the study conduct, to provide real-world examples, and to characterize the mindset and skill sets that are valuable in the conduct of a clinical trial. Because of the complexity and the breadth of topics, no single book chapter can extensively describe all the information that is necessary for an investigator to embark on a study.

In its simplest form, a clinical trial is an experiment in humans designed to compare treatments. All the major landmark surgical oncology trials have been "controlled clinical trials," which are defined by Meinert and Tonascia as "a clinical trial involving one or more test treatments, at least one control treatment, and concurrent enrollment, treatment and follow-up of all patients in the trial."1 The conduct of that trial comprises a sequence of steps necessary to bring that trial to completion. It requires the recruitment of a sufficient sample size of evaluable study population, the administration of the assigned therapies, and the construction of a database of sufficiently high integrity that will be available for analysis by the study statisticians and the drawing of conclusions by the study scientists.

If the "conduct" of a clinical trial were a simple matter, it would not have evolved into the major industry that it has become today, with thousands of books, peer-reviewed articles, and other scientific publications devoted to the subject and with hundreds of contract research organizations promoting their services. When considering the factors necessary to mount a clinical trial, investigators must have access to all available information and proceed in a systematic, controlled, methodologic progression.

The clinical trial protocol document serves as the plan for how the trial is to be conducted. There should be a strong relationship between this document and the ensuing conduct of the protocol. The successful conduct of the trial will be enhanced if the individuals responsible for carrying out the trial participate in the development of the protocol document. Review by these individuals should concentrate on the logistical aspects of the protocol, including eligibility assessment, subject recruitment, treatment administration, and follow-up surveillance. Their review should ensure that the protocol is internally consistent with respect to these factors and that the protocol clearly defines the logistics of entry, treatment, ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.